Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-10-28Clinical Trial Update: Instillation of Gemcitabine in Patients With Superficial Bladder Cancer [Phase 3]
A Phase 3 trial evaluating intravesical gemcitabine for superficial bladder cancer was terminated, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors [Phase 1]
Phase 1 trial comparing oral picoplatin with intravenous picoplatin in patients with solid tumors has been completed, evaluating safety and …
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 trial of TOCOSOL Paclitaxel for metastatic or locally advanced unresectable transitional cell carcinoma of the urothelium has comple…
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: Cost-Effectiveness in Bladder Cancer
This document reports a cost-effectiveness analysis in bladder cancer conducted by Erasmus Medical Center. It summarizes the economic evalua…
-
CLINICAL_TRIALS trial_result · 2008-11-07Clinical Trial Update: Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia
An update on changes in prostate-specific antigen (PSA) levels observed during Synergo intravesical chemotherapy with hyperthermia for bladd…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-15Clinical Trial Update: Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT [Phase 2]
A Phase II study evaluating gemcitabine and cisplatin with or without Iressa for bladder cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2008-10-03Clinical Trial Update: Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure [Phase 1]
A Phase 1 dose-escalation trial of CG0070 for bladder cancer after BCG failure is described; the current status in the entry is unknown.
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of cisplatin, paclitaxel, and gemcitabine in patients with progressive unresectable region…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors
This clinical trial update concerns the evaluation of antiangiogenic effects of Bacillus Calmette-Guérin (BCG) in bladder cancer. The study …
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: A Study of MLN8054 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of MLN8054 in patients with advanced solid tumors was terminated; the trial evaluated safety and dosing in breast cancer, colo…
-
CLINICAL_TRIALS trial_result · 2008-03-14Clinical Trial Update: Survivin Urine mRNA Assay Risk of Bladder Cancer Study
This entry notes the completed clinical trial evaluating the survivin urine mRNA assay as a biomarker for assessing bladder cancer risk.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder [Phase 1]
This entry reports the completion of a Phase I trial evaluating suramin for superficial transitional cell carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2007-07-31Clinical Trial Update: Weekly TP-HDFL in the Treatment of Advanced TCC [Phase 2]
This update reports a completed Phase 2 trial evaluating weekly TP-HDFL for advanced bladder cancer (transitional cell carcinoma).
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Intravesical Chemotherapy Treatment of Superficial Bladder Cancer [Phase 2]
A Phase 2 trial by Eli Lilly evaluating intravesical chemotherapy for superficial bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant gemcitabine and cisplatin with radical cystectomy or radiotherapy in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. [Phase 2]
Phase 2 trial evaluating intravesical gemcitabine instillation after transurethral resection for low-risk superficial bladder cancer; the st…
-
CLINICAL_TRIALS trial_result · 2006-09-27Clinical Trial Update: Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer [Phase 3]
Phase 3 trial comparing adjuvant versus progression-triggered gemcitabine monotherapy for locally advanced bladder cancer; trial status is c…
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating sequential gemcitabine and cisplatin followed by pemetrexed and gemcitabine in patients with advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
A Phase 2 study evaluated ALIMTA (pemetrexed) plus gemcitabine in locally advanced or metastatic urothelial carcinoma and has completed the …
-
CLINICAL_TRIALS trial_result · 2006-06-22Clinical Trial Update: Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Phase 2]
A completed Phase 2 trial evaluated intravesical epirubicin plus BCG for preventing recurrence in patients with transitional cell carcinoma …